Cc1nnc(O)c2c(NC(=O)COC(=O)c3ncc(Cl)c(Cl)c3Cl)oc(C)c12
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?